118 related articles for article (PubMed ID: 3503483)
1. Effects of flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat.
Luthy I; Caron S; Bélanger A; Labrie F
Gynecol Endocrinol; 1987 Jun; 1(2):151-68. PubMed ID: 3503483
[TBL] [Abstract][Full Text] [Related]
2. Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.
Spinola PG; Marchetti B; Mérand Y; Bélanger A; Labrie F
Breast Cancer Res Treat; 1988 Dec; 12(3):287-96. PubMed ID: 3147727
[TBL] [Abstract][Full Text] [Related]
3. In vitro transfer rate of 14C from acetate-1-14C into ovarian steroids in the rat ovary during the estrous cycle and effects of LH and FSH.
Kimura F; Ishida S; Seto K; Kawakami M
Endokrinologie; 1976 Jun; 67(2):172-83. PubMed ID: 986298
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
5. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
[TBL] [Abstract][Full Text] [Related]
6. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat.
Tébar M; Ruíz A; Bellido C; Sánchez-Criado JE
Biol Reprod; 1996 Jun; 54(6):1266-70. PubMed ID: 8724354
[TBL] [Abstract][Full Text] [Related]
7. The rise in testicular androgens during the first days of treatment with an LHRH agonist in the dog can be blocked by aminoglutethimide or ketoconazole.
Lacoste D; St-Arnaud R; Caron S; Belanger A; Labrie F
J Steroid Biochem; 1988 Dec; 31(6):963-70. PubMed ID: 3059065
[TBL] [Abstract][Full Text] [Related]
8. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
Couzinet B; Pholsena M; Young J; Schaison G
Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.
Simard J; Luthy I; Guay J; Bélanger A; Labrie F
Mol Cell Endocrinol; 1986 Mar; 44(3):261-70. PubMed ID: 3956856
[TBL] [Abstract][Full Text] [Related]
10. Effects of an anti-androgen and 5 alpha-reductase inhibitors on estrus duration in the cycling female rat.
Erskine MS
Physiol Behav; 1983 Apr; 30(4):519-24. PubMed ID: 6683842
[TBL] [Abstract][Full Text] [Related]
11. Clinical and endocrine effects of flutamide in hyperandrogenic women.
Fruzzetti F; De Lorenzo D; Ricci C; Fioretti P
Fertil Steril; 1993 Nov; 60(5):806-13. PubMed ID: 8224265
[TBL] [Abstract][Full Text] [Related]
12. Progesterone secretion by granulosa cells from rats with four- or five-day estrous cycles: the development of responses to follicle-stimulating hormone, luteinizing hormone, and testosterone.
Quirk SM; Hilbert JL; Fortune JE
Endocrinology; 1986 Jun; 118(6):2402-10. PubMed ID: 3084218
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
15. Similarities and differences in progesterone and androgens in modulation of LH, FSH and PRL release: unexpected properties of flutamide.
Brann DW; Putnam CD; Mahesh VB
J Steroid Biochem; 1990 Jul; 36(4):287-94. PubMed ID: 2118203
[TBL] [Abstract][Full Text] [Related]
16. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
[TBL] [Abstract][Full Text] [Related]
17. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis.
Schmidt WN; Katzenellenbogen BS
Mol Cell Endocrinol; 1979 Aug; 15(2):91-108. PubMed ID: 499651
[TBL] [Abstract][Full Text] [Related]
18. Enhanced ovarian gonadotropin receptors in the testosterone-induced polycystic ovary in rats.
Ota H; Wakizaka A; Fukushima M; Maki M
Tohoku J Exp Med; 1986 Mar; 148(3):313-25. PubMed ID: 3010503
[TBL] [Abstract][Full Text] [Related]
19. Interference with the preovulatory luteinizing hormone surge and blockade of ovulation in immature pregnant mare's serum gonadotropin-primed rats with the anti-androgenic drug, hydroxyflutamide.
Opavsky MA; Chandrasekhar Y; Roe M; Armstrong DT
Biol Reprod; 1987 Apr; 36(3):636-42. PubMed ID: 3593836
[TBL] [Abstract][Full Text] [Related]
20. Effect of the antiandrogen flutamide on pituitary LH content and release.
Sardañons ML; de las Heras MA; Calandra RS; Solano AR; Podestá EJ
Neuroendocrinology; 1989 Aug; 50(2):211-6. PubMed ID: 2674764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]